Proteome Sciences plc
PRM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £24 | £23 |
| % Growth | -2.8% | -100% | 5.1% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 13.7% | 32.8% | 0% | 0% |
| EBITDA | -£0 | -£0 | £0 | £0 |
| % Margin | -31% | -22.6% | 0% | 0% |
| Net Income | -£0 | -£0 | £0 | £0 |
| % Margin | -69.7% | -48.6% | 0% | 0% |
| EPS Diluted | -0.012 | -0.008 | 0.004 | 0 |
| % Growth | -38.6% | -293% | 2,050% | – |
| Operating Cash Flow | -£0 | -£0 | £4 | £11 |
| Capital Expenditures | -£0 | -£0 | -£2 | -£2 |
| Free Cash Flow | -£0 | -£0 | £2 | £9 |